Achieving Intraperitoneal Disease Control Using Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Two Cases of Metastatic Breast Cancer

In conclusion, CRS/HIPEC is safe and can provide intraperitoneal disease and symptom control in select patients with PMBC. Thus, CRS/HIPEC can be offered to these rare patients who have failed standard treatments.PMID:37303429 | PMC:PMC10250112 | DOI:10.7759/cureus.38767

Source: Cancer Control - June 12, 2023 Category: Cancer & Oncology Authors: Philipp Barakat Vadim Gushchin Luis Felipe Falla Zuniga Mary Caitlin King Armando Sardi Source Type: research